+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Tissue Diagnostics Market by Product (Accessories, Consumables, Instruments), Technology (Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization), Indications, End-User - Forecast 2023-2030- Product Image
Global Tissue Diagnostics Market by Product (Accessories, Consumables, Instruments), Technology (Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization), Indications, End-User - Forecast 2023-2030- Product Image
Sale

Global Tissue Diagnostics Market by Product (Accessories, Consumables, Instruments), Technology (Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization), Indications, End-User - Forecast 2023-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989888
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tissue Diagnostics Market size was estimated at USD 7.71 billion in 2022, USD 8.30 billion in 2023, and is expected to grow at a CAGR of 7.74% to reach USD 14.02 billion by 2030.

Tissue diagnostics is a medical field that involves examining and analyzing tissue samples from a patient's body to diagnose diseases or conditions. It is crucial in diagnosing and treating various medical conditions, including cancer and other tissue-related diseases. Tissue diagnostics has applications across several clinical areas and is crucial in personalized medicine for assisting in early disease detection. An increase in global cancer prevalence rates and an aging population drive the demand for tissue diagnostic services. Advancements in genomics have led to the identification of numerous biomarkers associated with diseases, which have further spurred the need for accurate diagnostic tests. However, high costs associated with diagnostic instruments and services might impede their adoption by small-scale healthcare providers or low-resource settings. The lack of skilled professionals capable of interpreting complex test results and insufficient pathologists worldwide could hinder market expansion. Technological advances such as artificial intelligence (AI) integration with digital pathology have opened up new opportunities for the market players. AI-based algorithms can aid pathologists in detecting subtle morphological changes within tissues that may be easily overlooked. Additionally, growing investments from governments and private organizations towards healthcare infrastructure are expected to provide more avenues for growth in this sector.

Regional Insights

The Americas has a significant landscape in the tissue diagnostics market owing to advanced healthcare infrastructure and extensive research funding by the key manufacturers in the development of diagnostics tests. The manufacturers in the region have observed numerous patents issued by the FDA for innovations in tissue diagnostics technology. The EMEA region has observed a developing landscape in the tissue diagnostics market due to significant investments made by the government to support research initiatives for early diagnosis of diseases such as cancer to improve diagnostic techniques. Government standards and regulations on the safety and quality of tissue diagnostics consumables have also contributed to the market growth in the region. South Africa is a hub for innovation within the African continent, with several ongoing research initiatives focused on developing efficient diagnostic tools that cater to local disease prevalence patterns. APAC region in the market has a developing growth due to technological advancements, investment in research and development of state-of-the-art tissue diagnostic technologies, increasing cancer incidence, and government initiatives encouraging local manufacturing of diagnostic equipment, fostering innovation within the country's tissue diagnostics industry.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tissue Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tissue Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tissue Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Agilent Technologies, Inc., Atlas Antibodies AB, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenex Laboratories Inc., BioIVT, LLC, bioMérieux SA, Cardinal Health, Inc., Castle Biosciences, Inc., Cell Signaling Technology, Inc., Diagnostic BioSystems Inc., F. Hoffmann-La Roche Ltd, Leica Biosystems by Danaher Corporation, McKesson Corporation, Merck KGaA, MILESTONE MEDICAL Srl, PathAI, Inc., Pfizer Inc., PROGEN Biotechnik GmbH, QIAGEN N.V., Quest Diagnostics Incorporated, Sekisui Diagnostics, LLC, Siemens Healthineers AG, SLEE medical GmbH, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Tissue Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Accessories
    • Consumables
      • Antibodies
      • Kits
      • Probes
      • Reagents
    • Instruments
      • Scanners
      • Slide-staining Systems
      • Tissue Microarrays
      • Tissue-processing Systems
    • Software
  • Technology
    • Digital Pathology & Workflow
    • Immunohistochemistry
    • In Situ Hybridization
    • Special Staining
  • Indications
    • Breast Cancer
    • Gastric Cancer
    • Lymphoma
    • Non Small Cell Lung Cancer
    • Prostate Cancer
  • End-User
    • Clinical Pathology
    • Contract Research Organization
    • Hospitals
    • Pharmaceutical Organizations
    • Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Tissue Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tissue Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the Tissue Diagnostics Market?
  4. What is the market share of the leading vendors in the Tissue Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the Tissue Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Tissue Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of cancer worldwide
5.1.1.2. Growing use of personalized medicine
5.1.1.3. Government initiatives to increase awareness regarding effective and early cancer diagnosis
5.1.2. Restraints
5.1.2.1. High cost involved in tissue diagnosis and reimbursement issues
5.1.3. Opportunities
5.1.3.1. Inception of digital pathology and automated tissue diagnostics
5.1.3.2. Innovative technologies and instruments development in tissue diagnostic field
5.1.4. Challenges
5.1.4.1. Limitations associated with tissue diagnostics procedures coupled with privacy concerns
5.2. Market Segmentation Analysis
5.2.1. Product: Proliferating use of tissue-processing systems for efficient processing and analyzing diagnosing tissue samples
5.2.2. Technology: Adoption of digital pathology technology for the management of digitized histological samples through computer technology
5.2.3. Indications: Exponential use of tissue diagnostics in the detection and characterization of numerous cancer types
5.2.4. End-User: Significant utilization of tissue diagnostics in clinical pathology laboratories to improve patient care quality
5.3. Market Trend Analysis
5.3.1. Significant emphasis on securing approvals for tissue diagnostic technologies in the Americas
5.3.2. Government initiatives to encourage early detection and screening of chronic diseases in the APAC region
5.3.3. Revolutionary advancements in tissue diagnostic technologies in the EMEA region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. Tissue Diagnostics Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Consumables
6.4.1. Antibodies
6.4.2. Kits
6.4.3. Probes
6.4.4. Reagents
6.4. Instruments
6.5.1. Scanners
6.5.2. Slide-staining Systems
6.5.3. Tissue Microarrays
6.5.4. Tissue-processing Systems
6.5. Software
7. Tissue Diagnostics Market, by Technology
7.1. Introduction
7.2. Digital Pathology & Workflow
7.3. Immunohistochemistry
7.4. In Situ Hybridization
7.5. Special Staining
8. Tissue Diagnostics Market, by Indications
8.1. Introduction
8.2. Breast Cancer
8.3. Gastric Cancer
8.4. Lymphoma
8.5. Non Small Cell Lung Cancer
8.6. Prostate Cancer
9. Tissue Diagnostics Market, by End-User
9.1. Introduction
9.2. Clinical Pathology
9.3. Contract Research Organization
9.4. Hospitals
9.5. Pharmaceutical Organizations
9.6. Research Laboratories
10. Americas Tissue Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Tissue Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Tissue Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Bio-Techne Buys Lunaphore to Boost Cancer Diagnostics Through Spatial Biology
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Ibex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer Diagnosis
13.3.2.2. Roche Expands Collaboration with Janssen to Advance Personalized Healthcare Through Companion Diagnostics
13.3.2.3. Guardant Health to Integrate Lunit's Ai-Based Scoring Algorithm for Pd-L1 into its Portfolio to Enhance Cancer Biomarker Detection
13.3.2.4. Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
13.3.3. New Product Launch & Enhancement
13.3.3.1. Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading
13.3.3.2. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
13.3.4. Investment & Funding
13.3.4.1. Ibex Raises USD 55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis
13.3.4.2. Lunaphore Secures Chf 40 Million to Boost Portfolio of Tissue Diagnostics Solutions
13.3.4.3. Microsoft Strikes Partnership with Paige to Advance Cancer Diagnostics and Treatment
13.3.5. Award, Recognition, & Expansion
13.3.5.1. PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services
13.3.5.2. Cytelabs expanding diagnostic services to hospitals and patients across south India
13.3.5.3. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
13.3.5.4. Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
13.3.5.5. ROCHE tissue diagnostics celebrates marana expansion project
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Abcam Plc
14.1.3. Agilent Technologies, Inc.
14.1.4. Atlas Antibodies AB
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. Bio-Techne Corporation
14.1.7. Biogenex Laboratories Inc.
14.1.8. BioIVT, LLC
14.1.9. bioMérieux SA
14.1.10. Cardinal Health, Inc.
14.1.11. Castle Biosciences, Inc.
14.1.12. Cell Signaling Technology, Inc.
14.1.13. Diagnostic BioSystems Inc.
14.1.14. F. Hoffmann-La Roche Ltd
14.1.15. Leica Biosystems by Danaher Corporation
14.1.16. McKesson Corporation
14.1.17. Merck KGaA
14.1.18. MILESTONE MEDICAL Srl
14.1.19. PathAI, Inc.
14.1.20. Pfizer Inc.
14.1.21. PROGEN Biotechnik GmbH
14.1.22. QIAGEN N.V.
14.1.23. Quest Diagnostics Incorporated
14.1.24. Sekisui Diagnostics, LLC
14.1.25. Siemens Healthineers AG
14.1.26. SLEE medical GmbH
14.1.27. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. TISSUE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. TISSUE DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TISSUE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2022 VS 2030 (%)
FIGURE 12. TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. TISSUE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TISSUE DIAGNOSTICS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 9. TISSUE DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TISSUE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TISSUE DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 15. TISSUE DIAGNOSTICS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TISSUE DIAGNOSTICS MARKET SIZE, BY SLIDE-STAINING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE-PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TISSUE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY & WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. TISSUE DIAGNOSTICS MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 26. TISSUE DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. TISSUE DIAGNOSTICS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. TISSUE DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. TISSUE DIAGNOSTICS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. TISSUE DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. TISSUE DIAGNOSTICS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 58. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 59. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 61. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 64. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 90. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 91. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 93. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 96. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 97. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 99. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 108. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 109. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 111. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 144. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 145. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 147. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 163. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 164. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 166. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 169. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 170. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 172. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 175. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 178. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 181. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 184. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 187. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 188. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 190. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 199. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 200. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 202. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 217. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 220. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 223. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 224. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 226. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 229. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 232. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 253. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 271. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 272. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 274. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 288. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 289. TISSUE DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Abcam Plc
  • Agilent Technologies, Inc.
  • Atlas Antibodies AB
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biogenex Laboratories Inc.
  • BioIVT, LLC
  • bioMérieux SA
  • Cardinal Health, Inc.
  • Castle Biosciences, Inc.
  • Cell Signaling Technology, Inc.
  • Diagnostic BioSystems Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems by Danaher Corporation
  • McKesson Corporation
  • Merck KGaA
  • MILESTONE MEDICAL Srl
  • PathAI, Inc.
  • Pfizer Inc.
  • PROGEN Biotechnik GmbH
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • SLEE medical GmbH
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 8.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.02 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology (ISH, Digital Pathology), By Application (Breast Cancer, Prostate Cancer), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology (ISH, Digital Pathology), By Application (Breast Cancer, Prostate Cancer), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Global Tissue Diagnostics Market by Product (Consumables (Antibodies, Reagents, Tissue, Probes), Instrument (Processing System, Scanner)), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Forecast to 2028 - Product Image

Global Tissue Diagnostics Market by Product (Consumables (Antibodies, Reagents, Tissue, Probes), Instrument (Processing System, Scanner)), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Forecast to 2028

  • Report
  • 254 Pages
  • Global
From
Tissue Diagnostics - Global Strategic Business Report - Product Image

Tissue Diagnostics - Global Strategic Business Report

  • Report
  • 552 Pages
  • Global
From
Tissue Diagnostic Global Market Report 2024 - Product Image

Tissue Diagnostic Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Tissue Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Tissue Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.